In a filing, Verona Pharma Plc ADR revealed its Chief Financial Officer Hahn Mark W unloaded Company’s shares for reported $4.56 million on Jun 11 ’25. In the deal valued at $11.40 per share,400,000 shares were sold. As a result of this transaction, Hahn Mark W now holds 12,278,992 shares worth roughly $1.13 billion.
Then, ZACCARDELLI DAVID sold 400,000 shares, generating $4,560,520 in total proceeds. Upon selling the shares at $11.40, the President and CEO now owns 13,190,168 shares.
Before that, DAVID ZACCARDELLI bought 50,000 shares. Verona Pharma Plc ADR shares valued at $4,339,000 were divested by the Director at a price of $86.78 per share.
TD Cowen initiated its Verona Pharma Plc ADR [VRNA] rating to a Buy in a research note published on April 28, 2025; the price target was $100. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who began to cover the stock in late April with a ‘”an Overweight”‘ rating. ROTH MKM began covering VRNA with “Buy” recommendation on January 10, 2025. Wells Fargo started covering the stock on October 03, 2024. It rated VRNA as “an Overweight”.
Price Performance Review of VRNA
On Friday, Verona Pharma Plc ADR [NASDAQ:VRNA] saw its stock fall -0.32% to $92.20. Over the last five days, the stock has gained 9.32%. Verona Pharma Plc ADR shares have risen nearly 98.54% since the year began. Nevertheless, the stocks have risen 589.60% over the past one year. While a 52-week high of $93.74 was reached on 06/12/25, a 52-week low of $14.14 was recorded on 01/10/25.
Levels Of Support And Resistance For VRNA Stock
The 24-hour chart illustrates a support level at 91.08, which if violated will result in even more drops to 89.97. On the upside, there is a resistance level at 93.39. A further resistance level may holdings at 94.59.
How much short interest is there in Verona Pharma Plc ADR?
A steep rise in short interest was recorded in Verona Pharma Plc ADR stocks on 2025-05-30, dropping by -0.87 million shares to a total of 7.13 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-30 was 8.0 million shares. There was a decline of -12.15%, which implies that there is a negative sentiment for the stock.
